| Financial Year |
March 31 2023 |
| Monetary Funds |
45,775,212.68 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,000,000.00 |
| Accounts Receivable |
583,326,144.97 |
| Advances to Suppliers |
10,146,272.77 |
| Other Receivables |
2,271,945.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,816,283.41 |
| Total Current Assets |
790,467,895.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
13,288,251.07 |
| Fixed Assetes |
14,660,692.32 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
40,163,015.69 |
| R&D expenses |
-- |
| Goodwill |
810,513.15 |
| Long-Term Deferred and Prepaid Expenses |
1,586,980.67 |
| Deferred Income Tax Assets |
23,686,445.26 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
176,923,289.16 |
| Total Assets |
967,391,184.48 |
| Short-Term Loans |
10,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
136,043,456.37 |
| Accounts Received In Advance |
2,952,185.01 |
| Employee Compensation Payable |
1,157,676.49 |
| Taxes Payable |
70,391,758.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
28,615,581.98 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,909,739.61 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
316,879,993.60 |
| Long-term Loans |
6,242,250.17 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,317,152.55 |
| Total Liabilities |
325,197,146.15 |
| Paid-In Capital(Or Share Stock) |
293,288,133.00 |
| Capital Surplus |
8,161,767.94 |
| Surplus Reserve |
38,747,998.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
295,252,947.53 |
| Minority Stockholder's Interest |
6,743,191.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
635,450,846.76 |
| Owner's Equity（Stockholder's Equity） |
642,194,038.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
967,391,184.48 |
